Abstract
The collaboration of drug information departments of two pharmaceutical firms that copromote a newly marketed drug is described. Differences in the backgrounds and philosophies of the two companies' drug information departments posed a challenge in coordinating their activities. The accommodations made by these two departments to meet the drug information needs of the copromoted drug are described.
Get full access to this article
View all access options for this article.